Company News
Morgan Stanley Upgrades Synopsys to Overweight
Morgan Stanley upgraded Synopsys to Overweight, keeping $500 price target based on 30‑35x forward P/E.
The upgrade cites attractive entry after recent de‑rating, confidence in Ansys acquisition synerg